Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
2(18%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph early_phase_1
1
9%
Ph not_applicable
5
45%
Ph phase_3
1
9%
Ph phase_2
3
27%

Phase Distribution

1

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
5(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed3
Recruiting2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (10.0%)
Phase 23 (30.0%)
Phase 31 (10.0%)
N/A5 (50.0%)

Trials by Status

terminated19%
completed327%
recruiting218%
unknown436%
not_yet_recruiting19%

Recent Activity

2 active trials
Showing 5 of 11
completednot_applicable

The Effect of Faecal Microbiota Transplantation (FMT) on Eradication of Multidrug Resistant Organisms (MRO) in Intestinal Carriers

NCT05742074
recruitingphase_2

Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases

NCT04924270
recruitingphase_2

Faecal Microbiota Transplantation for Liver Cirrhosis

NCT04932577
not_yet_recruitingnot_applicable

FMT for Insomnia Disorder (FMT-SLEEP)

NCT06606938
completedphase_3

Trial of Faecal Microbiota Transplantation in Cirrhosis

NCT02862249
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05742074Not Applicable

The Effect of Faecal Microbiota Transplantation (FMT) on Eradication of Multidrug Resistant Organisms (MRO) in Intestinal Carriers

Completed
NCT04924270Phase 2

Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases

Recruiting
NCT04932577Phase 2

Faecal Microbiota Transplantation for Liver Cirrhosis

Recruiting
NCT06606938Not Applicable

FMT for Insomnia Disorder (FMT-SLEEP)

Not Yet Recruiting
NCT02862249Phase 3

Trial of Faecal Microbiota Transplantation in Cirrhosis

Completed
NCT05556733Not Applicable

FMT for Post-acute COVID-19 Syndrome

Unknown
NCT05998174Early Phase 1

Faecal Microbiota Transplantation for Microscopic Colitis

Unknown
NCT04100291Not Applicable

Faecal Microbiota Transplantation in the Treatment of Chronic Pouchitis

Terminated
NCT04820413Not Applicable

Faecal Microbiota Transplantation From Normal Pouch Function Donor in the Treatment of Chronic Pouchitis

Completed
NCT03477032

FMT in Inflammatory Bowel Disease

Unknown
NCT02423421Phase 2

Faecal Microbiota Transplantation in Irritable Bowel Syndrome

Unknown

All 11 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
11